ClinConnect ClinConnect Logo
Search / Trial NCT05621642

Telerehabilitation Based Exercise Training in Parkinson's Patients

Launched by ISTANBUL UNIVERSITY - CERRAHPASA · Nov 14, 2022

Trial Information

Current as of August 11, 2025

Unknown status

Keywords

Telerehabilitation Balance Parkinson

ClinConnect Summary

Parkinson disease (PD) is the most common progressive, multisystemic and neurodegenerative disease after Alzheimer disease. Its prevalence increases with age and rises sharply around the age of 65 . The main pathological change is the progressive degeneration of neurons in the substantia nigra pars compacta, one of the nuclei forming then basal ganglia . Currently, pharmacological treatments are used primarily for symptomatic control and provide only short-term benefits before the disease progresses to a severe stage. Physical activity and exercise can provide cost-effective and universally...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Having been diagnosed with PH by a neurologist,
  • Being between 45 and 85 years old,
  • Being between I and III according to the modified Hoehn \& Yahr Staging (29)
  • To have a score of 24 or higher in the Mini Mental State Assessment (30),
  • To be taking their medication regularly.
  • Exclusion Criteria:
  • Having an orthopedic disability that will affect balance and mobility,
  • Those with serious chronic diseases that will significantly affect their quality of life (congestive heart failure, myocardial infarction),
  • Severe dyskinesia, cognitive problem that prevents cooperation,
  • Not having internet access with a smart phone or computer,

About Istanbul University Cerrahpasa

Istanbul University - Cerrahpasa is a prestigious academic institution renowned for its commitment to advancing medical research and education. With a focus on innovative clinical trials, the university harnesses cutting-edge methodologies to address pressing health challenges. Its collaborative environment fosters interdisciplinary research, enabling the development of effective therapeutic strategies and enhancing patient care. The institution's dedication to ethical standards and patient safety underscores its reputation as a leader in clinical research within the region and beyond.

Locations

Patients applied

0 patients applied

Trial Officials

Tuğba Argün Pulat

Principal Investigator

Doctor in hospital

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials